Biolinq, wearable biosensor platform developer, $62.2M
858 Therapeutics, biotechnology and drug discovery, $60M Series A with Versant Ventures and New Enterprise Associates
Ventyx Biosciences, clinical-stage biopharmaceutical company for autoimmune diseases, $51M Series B with Surveyor Capital and Wellington Management
Measurabl, ESG data management solution for real estate, $50M Series C with Energy Impact Partners and Salesforce Ventures
Truepic, camera technology developer for mobile devices, $26M Series B with M12 - Microsoft's Venture Fund and Adobe
GigaIO, high-speed interconnect hardware developer for computing clusters, $14.7M Series B with Impact Venture Capital and Four Palms Ventures
Eclipse Bioinnovations, RNA genomics, $12M
Cellibre, cellular agriculture, $9.9M
Lean Financial, financial technology, $4.5M Seed with Inspired Capital Partners and Oceans Ventures
9am.health, virtual diabetes clinic, $3.7M Seed with Founders Fund and Speedinvest